SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-031483
Filing Date
2019-08-12
Accepted
2019-08-12 16:16:44
Documents
44
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q eq-10q_20190630.htm 10-Q 1767518
2 EX-10.1 eq-ex101_162.htm EX-10.1 21690
3 EX-31.1 eq-ex311_7.htm EX-31.1 14275
4 EX-31.2 eq-ex312_8.htm EX-31.2 14364
5 EX-32.1 eq-ex321_6.htm EX-32.1 7275
  Complete submission text file 0001564590-19-031483.txt   4519700

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eq-20190630.xml EX-101.INS 872997
7 XBRL TAXONOMY EXTENSION SCHEMA eq-20190630.xsd EX-101.SCH 25803
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eq-20190630_cal.xml EX-101.CAL 32152
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eq-20190630_def.xml EX-101.DEF 66249
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eq-20190630_lab.xml EX-101.LAB 206520
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eq-20190630_pre.xml EX-101.PRE 151275
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38692 | Film No.: 191016697
SIC: 2834 Pharmaceutical Preparations